| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f76aab74ed312003383a8600e2edbd5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7455b32a77e26bea557102bc5952ce94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8545e38606ef61a629792f8850b2d9d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de6d2f09ced6ce3d88b2870b73323010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ddb91ce9ab728277ca81c5107cab324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26c475bcbe0c24b485b6f37c45cd921f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L79-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-6677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-0233 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L101-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-06 |
| filingDate |
2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d372e776c3409982496b8178a3cb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4b4a7ea9ffb91e5965d90cde377330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6ff0d5aadd623a7eded161f7913262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e06b2af2545d59a9faf701af32958142 |
| publicationDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009075744-A3 |
| titleOfInvention |
Curable benzoxazine-based compositions, their preparation and cured products thereof |
| abstract |
The invention relates to a curable composition comprising: at least one benzoxazine and at least one toughening additive which can be bound to the at least one benzoxazine in the curing process, characterized in that the toughening additive is distributed in the cured composition in form of discrete domains, and that at least 50% of the discrete domains related to the total amount of discrete domains having a maximum length in any direction of space in the range of 10 nm to 500 nm as determined by transmission electron microscopy (TEM). |
| priorityDate |
2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |